Propanc Receives $1.2 Million to Fast Track Animal Safety Studies, GMP Manufacturing and Preclinical Development for Lead Product, PRP Mar 21, 2016
Propanc Confirms PRP Response to Broad Range of Cancer Indications; Sets Date for Scientific Advice Meeting with UK Regulators Mar 2, 2016
Propanc Receives Additional $525,000 from Institutional Investor; Initiates Animal Safety Toxicology Studies for PRP Jan 13, 2016
